Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT02175823
  4. Details
NCT02175823 Clinical Trial

Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System

Cancer Clinical Trial

Official title:
Health Status Evaluation for Cancer Survivors by Non-intrusive Sensing System

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT02175823
Other study ID # 201401056RIND
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 25, 2014
Last updated July 3, 2014
Start date July 2014
Est. completion date July 2015

Study information
Verified date July 2014
Source National Taiwan University Hospital
Contact Li Chen Fu
Phone +886-2-3366-3558
Email lichen@ntu.edu.tw
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Observational

Clinical Trial Summary

To improve quality of life of elderly cancer survivors

1. Using physical activity and environmental sensing technology

2. Monitoring physiological indicators of cancer recurrence

- Analyzing the patient's circadian rhythm, frailty and his/her vital sign.

- Vital sign includes blood pressure, weight and hrv.

3. Collecting the patient information in real time

- Giving alarm information to the patient, if any special cases our system found.

- Giving circadian rhythm report to the patient.

- Giving healthy report to the patient, collected from his/her vital sign.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 40
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 65 Years and older
Eligibility Inclusion Criteria:

- The clinical pathology and diagnostic imaging to determine the cancer who completed acute treatment, and patients with more than a month recuperating.

- Over 65 years old.

- Proficient in Chinese or Taiwanese.

- Normal cognitive function

Exclusion Criteria:

- No history of cancer

- Over 65 years old.

- Proficient in Chinese or Taiwanese.

- Normal cognitive function

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Taiwan National Taiwan University Hospital Taipei Da'an Dist

Sponsors (1)
Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Quality of Life Three weeks Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients